Xarelto | The American Association For Justice

Xarelto

Description:

Xarelto® is one of several new prescription blood thinning medications introduced in recent years as an alternative to Coumadin® (warfarin sodium) as it does not require routine blood monitoring during treatment. However, use of Xarelto® causes serious and uncontrolled internal bleeding, which results in life-threatening injuries or death. There is currently no anticoagulant solution to stop bleeding complications that may develop among users.

The Xarelto® Litigation Group was founded for members to exchange knowledge and information and to provide opportunities for informational meetings and education programs regarding the Xarelto® litigation. The Xarelto® Litigation Group will also offer assistance and guidance in regard to the coordination of a future MDL and state court litigations. 

Background:

This Litigation Group was formed in July 2014.

Benefits & Resources:

The Xarelto® Litigation Group has a secure list server and a document library where members can share information, documents, and pertinent information as well as holds education programs.

Meetings:

AAJ Annual and Winter Conventions, or as needed by group members.

Cochairs:
Roger C. Denton
Schlichter Bogard & Denton
100 S. 4th St., Suite 900
Saint Louis, MO 63102
Phone: 314/621-6115
Fax: 314/621-7151
 
Neil E. McWilliams
Levin, Papantonio, Thomas, Mitchell, Rafferty &
Proctor, PA
316 S. Baylen St., Suite 600
Pensacola, FL 32502
Phone: 850/435-7165
Fax: 850/436-6165
PDF Application:
Dues:
$300/attorney, $100/additional attorney ($500 max)